CA2206012C - Composes nouveaux pour le traitement et la prevention du diabete - Google Patents

Composes nouveaux pour le traitement et la prevention du diabete Download PDF

Info

Publication number
CA2206012C
CA2206012C CA002206012A CA2206012A CA2206012C CA 2206012 C CA2206012 C CA 2206012C CA 002206012 A CA002206012 A CA 002206012A CA 2206012 A CA2206012 A CA 2206012A CA 2206012 C CA2206012 C CA 2206012C
Authority
CA
Canada
Prior art keywords
composition
insulin
niddm
treatment
ghp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002206012A
Other languages
English (en)
Other versions
CA2206012A1 (fr
Inventor
Hee-Sook Jun
Ji-Won Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastwood Biomedical Research Inc
Original Assignee
Eastwood Biomedical Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastwood Biomedical Research Inc filed Critical Eastwood Biomedical Research Inc
Priority to CA002206012A priority Critical patent/CA2206012C/fr
Priority to AU41077/97A priority patent/AU4107797A/en
Priority to PCT/CA1997/000621 priority patent/WO1998052587A1/fr
Publication of CA2206012A1 publication Critical patent/CA2206012A1/fr
Application granted granted Critical
Publication of CA2206012C publication Critical patent/CA2206012C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002206012A 1997-05-23 1997-05-23 Composes nouveaux pour le traitement et la prevention du diabete Expired - Lifetime CA2206012C (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002206012A CA2206012C (fr) 1997-05-23 1997-05-23 Composes nouveaux pour le traitement et la prevention du diabete
AU41077/97A AU4107797A (en) 1997-05-23 1997-09-02 Compounds for the treatment and prevention of diabetes
PCT/CA1997/000621 WO1998052587A1 (fr) 1997-05-23 1997-09-02 Composes pour le traitement et la prevention du diabete

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002206012A CA2206012C (fr) 1997-05-23 1997-05-23 Composes nouveaux pour le traitement et la prevention du diabete

Publications (2)

Publication Number Publication Date
CA2206012A1 CA2206012A1 (fr) 1998-11-23
CA2206012C true CA2206012C (fr) 2007-05-22

Family

ID=4160724

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002206012A Expired - Lifetime CA2206012C (fr) 1997-05-23 1997-05-23 Composes nouveaux pour le traitement et la prevention du diabete

Country Status (3)

Country Link
AU (1) AU4107797A (fr)
CA (1) CA2206012C (fr)
WO (1) WO1998052587A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551627B1 (en) * 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
GB0623618D0 (en) * 2006-11-27 2007-01-03 Mars Uk Ltd Composition
WO2011078652A1 (fr) * 2009-12-21 2011-06-30 Biotropics Malaysia Berhad Extraits d'orthosiphon stamineus ayant une utilisation bénéfique en tant qu'agent d'amélioration de la cognition
EP3024471B1 (fr) 2013-07-22 2019-10-30 Université du Québec à Chicoutimi Utilisation d'extraits de plantes contre le virus de l'herpès simplex
EA032673B1 (ru) 2015-09-03 2019-06-28 Юнилевер Н.В. Съедобная композиция

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55122715A (en) * 1979-03-13 1980-09-20 Res Inst For Prod Dev Antidiabetic agent
CN1074350A (zh) * 1992-01-16 1993-07-21 曹富生 糖尿病人用饮料的制备方法
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
RO106508B1 (ro) * 1993-01-05 1993-05-31 Constantin Ionescu Medicament fitoterapeutic, destinat tratamentului diabetului zaharat, non-insulinodependent
JPH0717856A (ja) * 1993-06-30 1995-01-20 Tsumura & Co アルドースリダクターゼ阻害剤

Also Published As

Publication number Publication date
AU4107797A (en) 1998-12-11
CA2206012A1 (fr) 1998-11-23
WO1998052587A1 (fr) 1998-11-26

Similar Documents

Publication Publication Date Title
US6551627B1 (en) Medicinal herbal compounds for the prevention and treatment of diabetes
Dey et al. Alternative therapies for type 2 diabetes
Soumyanath Traditional medicines for modern times: antidiabetic plants
Shukia et al. Medicinal plants for treatment of diabetes mellitus
Bnouham et al. Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990-2000)
US7674486B2 (en) Synergistic composition for the treatment of diabetes mellitus
Deshmukh et al. Antihyperglycaemic activity of alcoholic extract of Aerva lanata (L.) AL Juss. Ex JA Schultes leaves in alloxan induced diabetic mice
Kaczmar Herbal support for diabetes management
Helal et al. Effect of Aloe vera extract on some physiological parameters in diabetic albino rats.
CA2206012C (fr) Composes nouveaux pour le traitement et la prevention du diabete
US9566308B2 (en) Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
Azhagarasi et al. Anti Diabetetic Activity of Illupai Ver Chooranam on Streptozotocin Diabetic Rats.(2022)
Madhavan et al. Antihyperglycemic activity of alcohol and aqueous extracts of pandanus fascicularis lam. roots in alloxan induced diabetic rats
Hadi E4An ultrastructural study by transmission electron microscope of exocrine pancreatic cells in diabetic rats treated with herbal combination
Offor et al. Effects of Aloe barbadensis and Cymbopogon citratus on Blood Glucose Levels of Alloxan–Induced Diabetic Albino Rats
Upadhayay et al. Evaluation of antidiabetic activity of fruits of withahnia coagulans in streptozocin induced diabetic rats
Majeed et al. Diabetes management: The therapeutic role of Ayurvedic herbs
Ashutosh et al. EVALUATION OF ANTIDIABETIC ACTIVITY OF FRUITS OF WITHAHNIA COAGULANS IN STREPTOZOCIN INDUCED DIABETIC RATS
Malik et al. Anti-hyperglycemic effect of aloe Vera leaf gel extract in alloxan induced diabetic rabbits
Shaheen et al. Diabetes mellitus: An overview and management with herbs
Soltani Prevention of Diabetes Complications
Sahu et al. Natural products with potent hypoglycemic activity
Majekodunmi et al. Current status of some tropical plants with anti-diabetic potential–a Review
Kumai et al. Hepatoprotective activity of Azadiracta indica leaves on Alloxan induced diabetic swiss albino mice
OZOUGWU HERBAL MEDICINE AND DIABETES MELLITUS MANAGEMENT

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170523